Royalty Pharma Plc(RPRX)— 技術面狀態
數據截至2026-10-14 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades -0.2% vs the 50-day and +14.2% vs the 200-day average, 8.4% below the 52-week high and +68.7% off the 52-week low. Computed from daily closes.
移動平均線狀態
- 相對20日均線+2.2%
- 相對50日均線-0.2%
- 相對200日均線+14.2%
- 52週區間低於52週高點8.4% · 高於52週低點68.7%
- 連續走勢連續1個交易日上漲
- 50日均線交叉股價向下穿越50日均線(24個交易日前)
- 隨機指標%K 98 · %D 50.9(黃金交叉)
FAQ · from the current data · as of 2026-10-14
Quick answers
RPRX目前的Closelook訊號是什麼?
Pullback inside an uptrend stack — Trades -0.2% vs the 50-day and +14.2% vs the 200-day average, 8.4% below the 52-week high and +68.7% off the 52-week low. Computed from daily closes.(截至2026-10-14;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
RPRX目前是否位於50日與200日均線上方?
截至2026-10-14,Royalty Pharma Plc位於50日均線下方(-0.2%),200日均線上方(+14.2%);距20日均線+2.2%。
RPRX距52週高點有多遠?
截至2026-10-14,低於52週高點8.4%,高於52週低點68.7%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- UCB.BR UCB SAindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- EXEL Exelixis Incindustry
- RXRX Recursion Pharmaceuticals Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- RVMD Revolution Medicines Incindustry
- BION.SW BB Biotech AGindustry
- ROIV Roivant Sciences Ltdindustry
- INCY Incyte Corporationindustry